Heterocyclic compound
AssigneeTakeda Pharmaceutical Company Limited
InventorsHiroshi NARA, Masaki DAINI, Akira KAIEDA, Taku KAMEI, Toshihiro IMAEDA, Fumiaki KIKUCHI
Life of this patent
Estimating the term…
Loading patent…
AssigneeTakeda Pharmaceutical Company Limited
InventorsHiroshi NARA, Masaki DAINI, Akira KAIEDA, Taku KAMEI, Toshihiro IMAEDA, Fumiaki KIKUCHI
Estimating the term…
The present invention provides a compound having a superior JAK inhibitory action, which is useful as an agent for the prophylaxis or treatment of autoimmune diseases (rheumatoid arthritis, psoriasis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus, etc.), cancer (leukemia, uterine leiomyosarcoma, prostate cancer, multiple myeloma, cachexia, myelofibrosis, etc.) and the like, or a salt thereof. The present invention relates to a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.
A compound represented by the formula (I):
Dependencies are inferred from the claim text.